Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution
KR Suchin, AJ Cucchiara, SL Gottleib… - Archives of …, 2002 - jamanetwork.com
Objective To determine the efficacy of multimodality biologic response therapy for patients
with cutaneous T-cell lymphoma (CTCL). Design Retrospective cohort study over a 14-year
period. Setting Tertiary care university hospital. Patients A consecutive sample of patients
was studied, all 47 of whom carried the clinical and laboratory diagnosis of CTCL: 68% of
patients had stage III or IV disease, and 89% had circulating malignant T cells. Interventions
All 47 patients received photopheresis for 6 or more cycles. Thirty-one patients received …
with cutaneous T-cell lymphoma (CTCL). Design Retrospective cohort study over a 14-year
period. Setting Tertiary care university hospital. Patients A consecutive sample of patients
was studied, all 47 of whom carried the clinical and laboratory diagnosis of CTCL: 68% of
patients had stage III or IV disease, and 89% had circulating malignant T cells. Interventions
All 47 patients received photopheresis for 6 or more cycles. Thirty-one patients received …